Page last updated: 2024-10-31

metyrapone and Local Neoplasm Recurrence

metyrapone has been researched along with Local Neoplasm Recurrence in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research Excerpts

ExcerptRelevanceReference
"A long-term recurrence rate of Cushing's disease ranging from 2%-25% has been reported."1.39[Predictors of long-term remission after transsphenoidal surgery in Cushing's disease]. ( Abellán Galiana, P; Escrivá, CM; Fajardo Montañana, C; Gómez Vela, J; Lillo, VR; Riesgo Suárez, PA, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Saishouji, F1
Maeda, S1
Hamada, H1
Kimura, N1
Tamanoi, A1
Nishida, S1
Sakaguchi, M1
Igata, M1
Yokoo, K1
Kawakami, F1
Araki, E1
Kondo, T1
Abellán Galiana, P1
Fajardo Montañana, C1
Riesgo Suárez, PA1
Gómez Vela, J1
Escrivá, CM1
Lillo, VR1

Other Studies

2 other studies available for metyrapone and Local Neoplasm Recurrence

ArticleYear
Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report.
    BMC endocrine disorders, 2022, Jul-19, Volume: 22, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aged, 80 and over; Cat

2022
[Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2013, Volume: 60, Issue:8

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenal Insufficiency; Adrenocorticotropic Ho

2013